English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
生物通
11 小时
靶向 EZH2:杜氏肌营养不良症治疗新曙光
目前,虽然基因编辑疗法为 DMD 的治疗带来了一丝希望,但临床应用的道路上仍布满荆棘,比如难以确定临床疗效、无法有效控制潜在的脱靶效应等。而糖皮质激素(如地夫可特、泼尼松)虽能延缓疾病进展,却也伴随着肥胖、行为改变、身材矮小和骨质减少等诸多副作用,就像 “饮鸩止渴”,让患者陷入两难境地。因此,寻找更安全有效的治疗方法,成为了医学领域亟待攻克的难题。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Pleads not guilty
Israeli attack in Gaza
Chiefs sign Tillery
Kellogg's envoy role reduced
Syed formally resentenced
Staff placed on leave
North Macedonia deadly fire
Child abuse images sentence
US expels SA ambassador
Kupp signs with Seahawks
Survives 95 days at sea
Gold rises to new heights
Villanova fires head coach
Coffee creamer recall
Wins longest-ever Iditarod
Electrical fire halts show
Second protester arrested
Influencer leaves Australia
To review F-35 jets purchase
Felony gun possession arrest
Man wins $50M over burns
Deportation order blocked
Cuba suffers power outage
Texas measles outbreak
Laceration hazard recall
US launches strikes in Yemen
RU, UKR launch attacks
ISIS leader killed in Iraq
Trump signs funding bill
Withdraws nomination
Severe weather outbreak
反馈